Viki Rajendra Chopda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Viki Rajendra Chopda has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Anurag Singh Rathore
Department of Chemical Engineering Indian Institute of Technology Delhi New Delhi India
3 shared publications - James Gomes
Neurodegenerative Biology & System Biology Lab, Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, Hauz Khas, New Delhi 110016, India
3 shared publications Laxmi Adhikary
Upstream Process Development, R&D Intas Pharmaceuticals Limited, Biopharma Division Ahmedabad Gujarat India
3 shared publicationsDeeksha Saripalla
Research and Development Department Intas Pharmaceuticals Limited, Biopharma Division Ahmedabad Gujarat India
2 shared publicationsJames Gomes
Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, Hauz Khas, New Delhi, India
2 shared publications- Jashwant Kumar
Research and Development Department Intas Pharmaceuticals Limited, Biopharma Division Ahmedabad Gujarat India
2 shared publications
Latest Publications
- 11 March 2026
- Published by Wiley in Biotechnology Progress
- Vol. 42 (3) , e88503
A practical framework for clone selection, media‐feed screening, and upstream process parameter optimization for a mAb CHO cell culture process
This study presents a data‐driven workflow for upstream process development in biologics manufacturing, aimed at improving consistency, efficiency, and decision‐making using established statistical and machine learning tools. Rather than relying on subjective interpretation, the framework integrates multiple analytical methods in a structured manner to support key process development decisions. For clone selection, K ‐means clustering was applied and benchmarked with hierarchical clustering to identify top‐performing candidates from a large clone pool. By incorporating multiple product quality attributes into the evaluation, the approach improves selection consistency and reduces subjectivity. In the media and feed screening stage, principal component analysis (PCA) was used to explore how specific combinations influence glycosylation patterns, enabling rapid identification of promising conditions for further optimization while reducing experimental burden. For upstream process parameter refinement, a sequential learning strategy based on multi‐objective Bayesian optimization (MOBO) was applied to adaptively explore trade‐offs among competing quality attributes and titer. This approach enabled more efficient identification of improved operating conditions compared with static experimental designs while minimizing experimental runs. While the methods used are well‐established, their structured integration into a cohesive workflow demonstrates practical utility for industrial applications. Aligned with Bioprocessing 4.0 principles, this approach supports improved process understanding and informed decision‐making in upstream bioprocess development.
- 11 March 2026
- Published by Wiley in Biotechnology Progress
- Vol. 42 (3) , e88503
A practical framework for clone selection, media‐feed screening, and upstream process parameter optimization for a mAb CHO cell culture process
This study presents a data‐driven workflow for upstream process development in biologics manufacturing, aimed at improving consistency, efficiency, and decision‐making using established statistical and machine learning tools. Rather than relying on subjective interpretation, the framework integrates multiple analytical methods in a structured manner to support key process development decisions. For clone selection, K ‐means clustering was applied and benchmarked with hierarchical clustering to identify top‐performing candidates from a large clone pool. By incorporating multiple product quality attributes into the evaluation, the approach improves selection consistency and reduces subjectivity. In the media and feed screening stage, principal component analysis (PCA) was used to explore how specific combinations influence glycosylation patterns, enabling rapid identification of promising conditions for further optimization while reducing experimental burden. For upstream process parameter refinement, a sequential learning strategy based on multi‐objective Bayesian optimization (MOBO) was applied to adaptively explore trade‐offs among competing quality attributes and titer. This approach enabled more efficient identification of improved operating conditions compared with static experimental designs while minimizing experimental runs. While the methods used are well‐established, their structured integration into a cohesive workflow demonstrates practical utility for industrial applications. Aligned with Bioprocessing 4.0 principles, this approach supports improved process understanding and informed decision‐making in upstream bioprocess development.
- 23 October 2025
- Published by Wiley in Biotechnology Progress
- Vol. 42 (1) , e70086
Optimizing monoclonal antibody biosimilar production via transfer and active learning for targeted quality profiles
Biosimilar development of monoclonal antibodies (mAbs) is gaining significant momentum as numerous blockbuster biologics approach their patent expiry in the current decade. A critical challenge in biosimilar development lies in achieving product quality attributes(PQAs) comparable to the innovator product. PQAs in upstream processing are influenced by multiple factors, including cell line selection, media composition, feeding strategy, supplements, and bioreactor process parameters, with physical parameter optimization playing a pivotal role in enhancing both product titer and modulating PQAs. In this study, we systematically evaluated the impact of physical process parameters—pH and temperature along with initial seeding density (ISD)—on N‐glycan profiles and charge variants across four biosimilar development projects (Projects 1–4). Stepwise regression models were developed between process parameters and product quality attributes using JMP software to establish parameter‐attribute relationships. Our results demonstrated that lowering culture pH reduced %acidic variants and %galactosylation while increasing %basic variants and %afucosylation (AF). Increased culture temperature resulted in an increase in %acidic variants and a decrease in %AF. This parameter‐attribute relationships knowledge base was directly applied in experimental design to expedite the development of a fifth mAb biosimilar development (Project 5), substantially reducing experimental iterations and development timelines, exemplifying the practical implementation of Bioprocessing 4.0 principles.
- 23 October 2025
- Published by Wiley in Biotechnology Progress
- Vol. 42 (1) , e70086
Optimizing monoclonal antibody biosimilar production via transfer and active learning for targeted quality profiles
Biosimilar development of monoclonal antibodies (mAbs) is gaining significant momentum as numerous blockbuster biologics approach their patent expiry in the current decade. A critical challenge in biosimilar development lies in achieving product quality attributes(PQAs) comparable to the innovator product. PQAs in upstream processing are influenced by multiple factors, including cell line selection, media composition, feeding strategy, supplements, and bioreactor process parameters, with physical parameter optimization playing a pivotal role in enhancing both product titer and modulating PQAs. In this study, we systematically evaluated the impact of physical process parameters—pH and temperature along with initial seeding density (ISD)—on N‐glycan profiles and charge variants across four biosimilar development projects (Projects 1–4). Stepwise regression models were developed between process parameters and product quality attributes using JMP software to establish parameter‐attribute relationships. Our results demonstrated that lowering culture pH reduced %acidic variants and %galactosylation while increasing %basic variants and %afucosylation (AF). Increased culture temperature resulted in an increase in %acidic variants and a decrease in %AF. This parameter‐attribute relationships knowledge base was directly applied in experimental design to expedite the development of a fifth mAb biosimilar development (Project 5), substantially reducing experimental iterations and development timelines, exemplifying the practical implementation of Bioprocessing 4.0 principles.
- Open Access
- 1 March 2025
- Published by Wiley
Optimizing mAb Biosimilar Production via Transfer and Active Learning for Fine-Tuning Physical Process Parameters for achieving Targeted N-Glycan and Charge Variant Profiles: Advancing Bioprocess 4.0
Biosimilar development of monoclonal antibodies (mAbs) is gaining significant momentum as numerous blockbuster biologics approach their patent expiry in the current decade. A critical challenge in biosimilar development lies in achieving product quality attributes comparable to the innovator product. The product quality attributes (PQAs) in upstream processing are influenced by multiple factors, including cell line selection, media composition, feed strategy, supplements, and bioreactor process parameters, with physical parameter optimization playing a pivotal role in enhancing both product titer and modulating PQAs. In this study, we systematically evaluated the impact of physical process parameters - pH, temperature, and initial seeding density - on N-glycan profiles and charge variants across four biosimilar development projects (Projects 1-4). Prediction models were developed using JMP software to establish parameter-attribute relationships. Our results demonstrated that lowering bioreactor pH reduced % acidic variants and % Afucosylation (AF) while increasing % basic variants and % galactosylation. Similarly, increased culture temperature resulted in lower % acidic variants and % AF. This knowledge base was successfully applied to expedite the development of a fifth mAb biosimilar development (Project 5), substantially reducing experimental iterations and development timelines, exemplifying the practical implementation of Bioprocessing 4.0 principles.
- 1 March 2025
- Published by Wiley
Open AccessOptimizing mAb Biosimilar Production via Transfer and Active Learning for Fine-Tuning Physical Process Parameters for achieving Targeted N-Glycan and Charge Variant Profiles: Advancing Bioprocess 4.0
Biosimilar development of monoclonal antibodies (mAbs) is gaining significant momentum as numerous blockbuster biologics approach their patent expiry in the current decade. A critical challenge in biosimilar development lies in achieving product quality attributes comparable to the innovator product. The product quality attributes (PQAs) in upstream processing are influenced by multiple factors, including cell line selection, media composition, feed strategy, supplements, and bioreactor process parameters, with physical parameter optimization playing a pivotal role in enhancing both product titer and modulating PQAs. In this study, we systematically evaluated the impact of physical process parameters - pH, temperature, and initial seeding density - on N-glycan profiles and charge variants across four biosimilar development projects (Projects 1-4). Prediction models were developed using JMP software to establish parameter-attribute relationships. Our results demonstrated that lowering bioreactor pH reduced % acidic variants and % Afucosylation (AF) while increasing % basic variants and % galactosylation. Similarly, increased culture temperature resulted in lower % acidic variants and % AF. This knowledge base was successfully applied to expedite the development of a fifth mAb biosimilar development (Project 5), substantially reducing experimental iterations and development timelines, exemplifying the practical implementation of Bioprocessing 4.0 principles.
- 1 September 2016
- Published by Elsevier in Bioresource Technology
- Vol. 215, 63-75
Knowledge management in a waste based biorefinery in the QbD paradigm
- 1 September 2016
- Published by Elsevier in Bioresource Technology
- Vol. 215, 63-75
Knowledge management in a waste based biorefinery in the QbD paradigm
- 8 December 2015
- Published by Wiley in Biotechnology Journal
- Vol. 11 (1) , 164-171
Bridging the gap between PAT concepts and implementation: An integrated software platform for fermentation
Bioreactor control significantly impacts both the amount and quality of the product being manufactured. The complexity of the control strategy that is implemented increases with reactor size, which may vary from thousands to tens of thousands of litres in commercial manufacturing. The Process Analytical Technology (PAT) initiative has highlighted the need for having robust monitoring tools and effective control schemes that are capable of taking real time information about the critical quality attributes (CQA) and the critical process parameters (CPP) and executing immediate response as soon as a deviation occurs. However, the limited flexibility that present commercial software packages offer creates a hurdle. Visual programming environments have gradually emerged as potential alternatives to the available text based languages. This paper showcases development of an integrated programme using a visual programming environment for a Sartorius BIOSTAT® B Plus 5L bioreactor through which various peripheral devices are interfaced. The proposed programme facilitates real‐time access to data and allows for execution of control actions to follow the desired trajectory. Major benefits of such integrated software system include: (i) improved real time monitoring and control; (ii) reduced variability; (iii) improved performance; (iv) reduced operator‐training time; (v) enhanced knowledge management; and (vi) easier PAT implementation.
- 8 December 2015
- Published by Wiley in Biotechnology Journal
- Vol. 11 (1) , 164-171
Bridging the gap between PAT concepts and implementation: An integrated software platform for fermentation
Bioreactor control significantly impacts both the amount and quality of the product being manufactured. The complexity of the control strategy that is implemented increases with reactor size, which may vary from thousands to tens of thousands of litres in commercial manufacturing. The Process Analytical Technology (PAT) initiative has highlighted the need for having robust monitoring tools and effective control schemes that are capable of taking real time information about the critical quality attributes (CQA) and the critical process parameters (CPP) and executing immediate response as soon as a deviation occurs. However, the limited flexibility that present commercial software packages offer creates a hurdle. Visual programming environments have gradually emerged as potential alternatives to the available text based languages. This paper showcases development of an integrated programme using a visual programming environment for a Sartorius BIOSTAT® B Plus 5L bioreactor through which various peripheral devices are interfaced. The proposed programme facilitates real‐time access to data and allows for execution of control actions to follow the desired trajectory. Major benefits of such integrated software system include: (i) improved real time monitoring and control; (ii) reduced variability; (iii) improved performance; (iv) reduced operator‐training time; (v) enhanced knowledge management; and (vi) easier PAT implementation.
- 1 November 2015
- Published by Elsevier in Bioresource Technology
- Vol. 196, 160-168
Maximizing biomass concentration in baker’s yeast process by using a decoupled geometric controller for substrate and dissolved oxygen
- 1 November 2015
- Published by Elsevier in Bioresource Technology
- Vol. 196, 160-168
Maximizing biomass concentration in baker’s yeast process by using a decoupled geometric controller for substrate and dissolved oxygen
- 14 November 2014
- Published by Wiley in Journal of Chemical Technology & Biotechnology
- Vol. 90 (4) , 583-589
Integrating systems analysis and control for implementing process analytical technology in bioprocess development
This paper provides a perspective on the increasingly critical role that systems analysis and process control play in bioprocess development today. This is of particular importance to the manufacturers of biotech therapeutics since the product quality is critical and depends on the process and its control. Because a large number of process variables and raw materials can influence the overall outcome of a bioprocess, the correct determination of the process trajectory is often an intensive exercise. A follow‐up involving design of a suitable process control strategy for implementation of process conditions would be logical. However, such an exercise can no longer consider each unit operation one at a time but rather requires holistic inclusion of all upstream and downstream unit operations for successfully meeting the global standards laid down by various regulatory agencies by exploring the potential of process analytical technology (PAT) to achieve bigger objectives. In this perspective, the focus is on the core issues associated with process integration and how these may influence future process development. © 2014 Society of Chemical Industry
- 14 November 2014
- Published by Wiley in Journal of Chemical Technology & Biotechnology
- Vol. 90 (4) , 583-589
Integrating systems analysis and control for implementing process analytical technology in bioprocess development
This paper provides a perspective on the increasingly critical role that systems analysis and process control play in bioprocess development today. This is of particular importance to the manufacturers of biotech therapeutics since the product quality is critical and depends on the process and its control. Because a large number of process variables and raw materials can influence the overall outcome of a bioprocess, the correct determination of the process trajectory is often an intensive exercise. A follow‐up involving design of a suitable process control strategy for implementation of process conditions would be logical. However, such an exercise can no longer consider each unit operation one at a time but rather requires holistic inclusion of all upstream and downstream unit operations for successfully meeting the global standards laid down by various regulatory agencies by exploring the potential of process analytical technology (PAT) to achieve bigger objectives. In this perspective, the focus is on the core issues associated with process integration and how these may influence future process development. © 2014 Society of Chemical Industry
- 1 July 2014
- Published by Elsevier in Biocatalysis and Agricultural Biotechnology
- Vol. 3 (3) , 86-89
Studying the effect of nature of glass surface on immobilization of glucose isomerase
- 1 July 2014
- Published by Elsevier in Biocatalysis and Agricultural Biotechnology
- Vol. 3 (3) , 86-89
Studying the effect of nature of glass surface on immobilization of glucose isomerase
- 10 January 2013
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 169 (4) , 1219-1240
Comparative Performance of Decoupled Input–Output Linearizing Controller and Linear Interpolation PID Controller: Enhancing Biomass and Ethanol Production in Saccharomyces cerevisiae
A decoupled input–output linearizing controller (DIOLC) was designed as an alternative advanced control strategy for controlling bioprocesses. Simulation studies of its implementation were carried out to control ethanol and biomass production in Saccharomyces cerevisiae and its performance was compared to that of a proportional–integral–derivative (PID) controller with parameters tuned according to a linear schedule. The overall performance of the DIOLC was better in the test experiments requiring the controllers to respond accurately to simultaneous changes in the trajectories of the substrate and dissolved oxygen concentration. It also exhibited better performance in perturbation experiments of the most significant parameters q S,max, q O2,max, and k s , determined through a statistical design of experiments involving 730 simulations. DIOLC exhibited a superior ability of constraining the process when implemented in extreme metabolic regimes of high oxygen demand for maximizing biomass concentration and low oxygen demand for maximizing ethanol concentration.
- 10 January 2013
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 169 (4) , 1219-1240
Comparative Performance of Decoupled Input–Output Linearizing Controller and Linear Interpolation PID Controller: Enhancing Biomass and Ethanol Production in Saccharomyces cerevisiae
A decoupled input–output linearizing controller (DIOLC) was designed as an alternative advanced control strategy for controlling bioprocesses. Simulation studies of its implementation were carried out to control ethanol and biomass production in Saccharomyces cerevisiae and its performance was compared to that of a proportional–integral–derivative (PID) controller with parameters tuned according to a linear schedule. The overall performance of the DIOLC was better in the test experiments requiring the controllers to respond accurately to simultaneous changes in the trajectories of the substrate and dissolved oxygen concentration. It also exhibited better performance in perturbation experiments of the most significant parameters q S,max, q O2,max, and k s , determined through a statistical design of experiments involving 730 simulations. DIOLC exhibited a superior ability of constraining the process when implemented in extreme metabolic regimes of high oxygen demand for maximizing biomass concentration and low oxygen demand for maximizing ethanol concentration.